v3.26.1
Consolidated Statements of Earnings - USD ($)
shares in Thousands, $ in Millions
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Revenues:    
Net earned premiums, principally supplemental health insurance [1] $ 3,310 $ 3,381
Net investment income 956 955
Net investment gains (losses) 49 (963)
Other income (loss) 31 25
Total revenues 4,346 3,398
Benefits and expenses:    
Benefits and claims, excluding reserve remeasurement 1,914 1,986
Reserve remeasurement (gains) losses (82) (41)
Total benefits and claims, net 1,832 1,945
Acquisition and operating expenses:    
Amortization of deferred policy acquisition costs 221 216
Insurance commissions 237 240
Insurance and other expenses 771 802
Interest expense 60 50
Total acquisition and operating expenses 1,289 1,308
Total benefits and expenses 3,121 3,253
Earnings before income taxes 1,225 145
Income taxes 206 116
Net earnings $ 1,019 $ 29
Net earnings per share:    
Basic (in dollars per share) $ 1.99 $ 0.05
Diluted (in dollars per share) $ 1.98 $ 0.05
Weighted-average outstanding common shares used in computing earnings per share (In thousands):    
Basic (in shares) 513,071 544,707
Diluted (in shares) 514,785 546,878
Cash dividends per share $ 0.61 $ 0.58
[1] Includes a gain (loss) of an immaterial amount for the three-month periods ended March 31, 2026 and 2025, respectively, related to remeasurement of the deferred profit liability for limited-payment contracts.